ANDA 217873, held by Steriscience. Succinylcholine Chloride.
As of Nov 16, 2026, ANDA 217873 (Succinylcholine Chloride), held by Steriscience, was first approved by FDA on Jul 9, 2024, with 1 approved supplement and 0 published complete response letters.
Succinylcholine Chloride Injection is indicated in adults and pediatric patients: as an adjunct to general anesthesia to facilitate tracheal intubation to provide skeletal muscle relaxation during surgery or mechanical ventilation INDICATIONS AND USAGE
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 9, 2024 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Succinylcholine Chloride100MG/5ML (20MG/ML) · solution;intramuscular, intravenous | Succinylcholine Chloride | Rx |
| Jun 8, 2026 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jul 9, 2024 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters